Two West Australian high school students place highly in international biotech competition

Following a rancorous and polarising public debate last year, the creation of embryonic stem cell lines through somatic cell nuclear transfer will become legal in Australia on June 12.

The Queensland government and a consortium of Queensland universities will together invest AUD$5 million in the Melbourne-based Australian Synchrotron.

Sydney-based devices company AtCor Medical has lodged its prospectus for an initial public offering (IPO) to raise AUD$15 million for expanding the US marketing and sales of its cardiovascular diagnostic device, SphygmoCor.

Jim Bishop, CEO of the Cancer Institute NSW, spoke about the state of play at the Institute 18 months after its launch, the progress it has made so far and its plans for the coming year at in Sydney last week.

Is the NSW Carr government -- the first state government to legislate for a moratorium on genetically modified crops -- having second thoughts?

Melbourne-based Cryptome Pharmaceuticals has launched its first public share offer, filing a prospectus to list on the ASX in October.